Skip to content

Progyny PGNY EPS (Diluted)

EPS (Diluted) at other companies

CVS Health logo
CVS HealthCVS
$2.30+63.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.90+0.7%
Natera, Inc. logo
Natera, Inc.NTRA
-$0.60-20.0%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$0.36+50.0%
Organon logo
OrganonOGN
$0.55+66.7%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$0.34+187%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's EPS (diluted)?
Progyny (PGNY) reported EPS (diluted) of $0.29 in Q1 2026.
How has Progyny's EPS (diluted) changed year-over-year?
Progyny's EPS (diluted) increased by 70.6% year-over-year, from $0.17 to $0.29.
What is the long-term trend for Progyny's EPS (diluted)?
Over 4 years (2021 to 2025), Progyny's EPS (diluted) has grown at a -0.4% compound annual growth rate (CAGR), from $0.66 to $0.65.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.